Bin Zhou

Bin Zhou

Auto-generated profile, based on publicly available information

Bin Zhou

Department of Gastric Surgery, Jiangsu Cancer Hospital & The Affiliated Cancer Hospital of Nanjing Medical University & Jiangsu Institute of Cancer Research, Nanjing, China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 May 2022 in Cell Communication and Signaling
Verified
Journal Article
Open access
PDF file
WXWeiguo Xu
Weiguo Xu
JZJunyu Zheng
Junyu Zheng
XWXiao Wang
Xiao Wang
BZBin Zhou
Bin Zhou
HCHuanqiu Chen
Huanqiu Chen
FYFeng Yan
Feng Yan
Background: As a new kind of non-coding RNAs (ncRNAs), tRNA derivatives play an important role in gastric carcinoma (GC). Nevertheless, the underlying mechanism tRNA derivatives were involved in was rarely illustrated. Methods: We screened out the tRNA derivative, tRF-Val-CAC-016, based on the tsRNA sequencing and demonstrated the effect tRF-Val-CAC-016 exerted on GC proliferation in vitro and in vivo. We applied Dual-luciferase reporter assay, RIP assay, and bioinformatic analysis to discover the downstream target of tRF-Val-CAC-016. Then CACNA1d was selected, and the oncogenic characteristics were verified. Subsequently, we detected the possible regulation of the canonical MAPK signaling pathway to further explore the downstream mechanism of tRF-Val-CAC-016. Results: As a result, we found that tRF-Val-CAC-016 was low-expressed in GC, and upregulation of tRF-Val-CAC-016 could significantly suppress the proliferation of GC cell lines. Meanwhile, tRF-Val-CAC-016 regulated the canonical MAPK signaling pathway by targeting CACNA1d. Conclusions: tRF-Val-CAC-016 modulates the transduction of CACNA1d-mediated MAPK signaling pathways to suppress the proliferation of gastric carcinoma. This study discussed the function and mechanism of tRF-Val-CAC-016 in GC for the first time. The pioneering work has contributed to our present understanding of tRNA derivative, which might provide an alternative mean for the targeted therapy of GC.

1 March 2022 in International Journal of General Medicine
Verified
Journal Article
Open access
PDF file
JWJian Wang
Jian Wang
HZHui Zhang
Hui Zhang
PSPeng Shao
Peng Shao
XZXu Zhang
Xu Zhang
BZBin Zhou
Bin Zhou
Purpose: Pancreatic adenocarcinoma has a poor prognosis and chemotherapy has its limitation due to tumor heterogeneity. It is essential to find novel targets involving in tumorigenesis of pancreatic adenocarcinoma. Growing evidences indicated that pyroptosis is involved in tumorigenesis of many cancers, but the relationship between pyroptosis and pancreatic adenocarcinoma still remains to be elucidated. Our object is to explore whether pyroptosis-related different expression genes have association with survivals of pancreatic adenocarcinoma patients and the mechanism they may participate in. Besides, we also analyzed their effect on immune cell infiltration in tumor microenvironment. Patients and Methods: We used the bioinformatic analysis tool including GEPIA, cBioPortal, STRING, GeneMANIA, R software 4.03 and TIMER2.0 to investigate the different expression, prognostic value, protein-protein interaction, gene ontology, pathway and effect of immune cell infiltration of pyroptosis-related genes in PAAD. Results: Many pyroptosis-related genes express differently between pancreatic adenocarcinoma and normal tissues and they are associated with survival of PAAD. GABARAP and IL18 may play a key role in tumorigenesis of PAAD, for they are connected with overall survival, disease free survival and pathological stages at the same time. The function of pyroptosis-related genes includes cytokine production, endopeptidase activity, regulation of inflammation and inflammasome complex and pyroptosis-related genes have effect on immune cells infiltration in PAAD microenvironment. Conclusion: Lots of pyroptosis-related DEGs may get involved in pathogenesis of PAAD and their high expression have an effect on survival. GABARAP and IL18 could be valuable research targets of PAAD.

1 December 2025 in Translational Cancer Research
Verified
Journal Article
Open access
PDF file
XYXinnian Yu
Xinnian Yu
ZLZhipeng Li
Zhipeng Li
YFYuqi Fu
Yuqi Fu
BZBin Zhou
Bin Zhou
SZShanliang Zhong
Shanliang Zhong
Background: Transfer RNA-derived small RNAs (tsRNAs) have been shown to participate in tumorigenesis and progression of human cancers. We aimed to identify dysregulated tsRNAs in esophageal cancer (EC) and uncover the underlying mechanisms. Methods: tsRNA profiles for EC were downloaded from MINTbase. We also detected expression levels of tsRNAs in EC tissues using tsRNA sequencing and real-time quantitative polymerase chain reaction (RT-qPCR). The functional roles of tRF-29-86J8WPMN1EJ3 in EC were investigated by transfecting EC cell lines with mimics of tRF-29-86J8WPMN1EJ3 and assessing phenotypes through colony formation, wound healing, and Transwell assays. Results: Totally, 210 differentially expressed tsRNAs were identified from MINTbase. In addition, 40 EC patients were recruited, and four paired EC and adjacent normal tissues were randomly selected for tsRNA sequencing, identifying 159 dysregulated tsRNAs, which were intersected with the 210 tsRNAs from MINTbase, obtaining three tsRNAs: tRF-28-P4R8YP9LOND5, tRF-29-86J8WPMN1EJ3, and tRF-29-P4R8YP9LONHK. Their expression levels were validated in 40 paired tissues. All three tsRNAs were up-regulated in EC tissues, and their high expression levels were associated with shorter overall survival (OS) in EC patients. In vitro experiments indicated that overexpression of tRF-29-86J8WPMN1EJ3 could promote proliferation, migration, and invasion of EC cell lines. Conclusions: In conclusion, we presented the expression characteristics of tsRNAs in EC and identified three up-regulated tsRNAs in EC tissues. Lower expression levels of these tsRNAs were associated with better OS in EC patients. Additionally, tRF-29-86J8WPMN1EJ3 promotes the proliferation, migration, and invasion of EC cells.